211 related articles for article (PubMed ID: 18538450)
1. Synthesis, antitubercular activity and docking study of novel cyclic azole substituted diphenyl ether derivatives.
Kini SG; Bhat AR; Bryant B; Williamson JS; Dayan FE
Eur J Med Chem; 2009 Feb; 44(2):492-500. PubMed ID: 18538450
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
Kini SG; Bhat A; Pan Z; Dayan FE
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
[TBL] [Abstract][Full Text] [Related]
3. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli.
Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A
Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of azetidine-, quinazoline-, and triazolo-thiadiazole-containing pyrazines.
Bonde CG; Peepliwal A; Gaikwad NJ
Arch Pharm (Weinheim); 2010 Apr; 343(4):228-36. PubMed ID: 20205198
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
[TBL] [Abstract][Full Text] [Related]
6. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel antitubercular compounds through hybrid virtual screening approach.
Muddassar M; Jang JW; Hong SK; Cho YS; Kim EE; Keum KC; Oh T; Cho SN; Pae AN
Bioorg Med Chem; 2010 Sep; 18(18):6914-21. PubMed ID: 20727773
[TBL] [Abstract][Full Text] [Related]
8. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase.
Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A
IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.
Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel molecules with a diphenyl ether nucleus as potential antitubercular agents.
Yang Y; Wang Z; Yang J; Yang T; Pi W; Ang W; Lin Y; Liu Y; Li Z; Luo Y; Wei Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):954-7. PubMed ID: 22197389
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Subba Rao G; Vijayakrishnan R; Kumar M
Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
[TBL] [Abstract][Full Text] [Related]
17. Rational design of InhA inhibitors in the class of diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulations.
Kamsri P; Koohatammakun N; Srisupan A; Meewong P; Punkvang A; Saparpakorn P; Hannongbua S; Wolschann P; Prueksaaroon S; Leartsakulpanich U; Pungpo P
SAR QSAR Environ Res; 2014; 25(6):473-88. PubMed ID: 24785640
[TBL] [Abstract][Full Text] [Related]
18. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-GĂ©nisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
20. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]